Skip to search formSkip to main contentSkip to account menu

24-norursodeoxycholic acid

Known as: 24-Norcholan-23-oic acid, 3,7-dihydroxy-, (3alpha,5beta,7beta)-, nor-UDCA 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Ursodiol
analogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Editorial: biologic therapies for primary sclerosing cholangitis—more disappointment than promise? Authors’ reply
Primary sclerosing cholangitis (PSC), an immune-mediated cholestatic liver disease characterised by chronic inflammation and… 
Review
2014
Review
2014
Therapeutic Role of Bile Acids and Nuclear Receptor Agonists in Fibrosing Cholangiopathies
Chronic inflammatory bile duct diseases such as primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) result… 
2010
2010
47 METABOLIC REPROGRAMMING OF LIPID METABOLISM BY THE SIDE-CHAIN MODIFIED BILE ACID, 24-NORURSODEOXYCHOLIC ACID, RESTORES INFLAMMATION-DRIVEN LIVER INJURY AND ABERRANT PROLIFERATION IN ABCB4−/− MICE
2000
2000
Sclerosing cholangitis.
Primary sclerosing cholangitis is a chronic cholestatic liver disease of unknown etiology. Immunogenetic factors are considered… 
1993
1993
5 beta-hydroxylation by the liver. Identification of 3,5,7-trihydroxy nor-bile acids as new major biotransformation products of 3,7-dihydroxy nor-bile acids in rodents.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)